Generex Biotechnology Corporation

OTCPK:GNBT Rapporto sulle azioni

Cap. di mercato: US$61.0k

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

Generex Biotechnology Gestione

Gestione criteri di controllo 2/4

Informazioni chiave

Joe Moscato

Amministratore delegato

n/a

Compenso totale

Percentuale dello stipendio del CEOn/a
Mandato del CEO5.4yrs
Proprietà del CEO0.4%
Durata media del management5.4yrs
Durata media del Consiglio di amministrazione5.4yrs

Aggiornamenti recenti sulla gestione

Recent updates

Analisi delle retribuzioni degli amministratori delegati

Come è cambiata la remunerazione di Joe Moscato rispetto agli utili di Generex Biotechnology?
DataCompenso totaleStipendioGuadagni aziendali
Apr 30 2021n/an/a

-US$37m

Jan 31 2021n/an/a

-US$52m

Oct 31 2020n/an/a

-US$35m

Jul 31 2020US$623kUS$623k

-US$33m

Apr 30 2020n/an/a

-US$26m

Jan 31 2020n/an/a

-US$31m

Oct 31 2019n/an/a

-US$36m

Jul 31 2019US$103kn/a

-US$9m

Apr 30 2019n/an/a

US$10m

Jan 31 2019n/an/a

US$24m

Oct 31 2018n/an/a

US$27m

Jul 31 2018US$100kn/a

US$36m

Apr 30 2018n/an/a

US$9m

Jan 31 2018n/an/a

-US$37m

Oct 31 2017n/an/a

-US$43m

Jul 31 2017US$50kn/a

-US$70m

Compensazione vs Mercato: Insufficient data to establish whether Joe's total compensation is reasonable compared to companies of similar size in the US market.

Compensazione vs guadagni: Joe's compensation has increased whilst the company is unprofitable.

AMMINISTRATORE DELEGATO

Joe Moscato (57 yo)

5.4yrs

Mandato

US$623,082

Compensazione

Mr. Joseph Moscato, also known as Joe, serves as Chief Executive Officer and Vice-Chairman of the Board at NuGenerex Immuno-Oncology, Inc. and served as its Chairman of the Board. Mr. Moscato has been the...

Gruppo dirigente

NomePosizioneMandatoCompensazioneProprietà
Joseph Moscato
CEO, President & Chairman of the Board5.4yrsUS$623.08k0.36%
$ 219.0
Mark Corrao
CFO & Treasurer5.4yrsUS$10.00k0%
$ 0
Terry Thompson
Chief Operating Officer4.4yrsUS$566.44k0%
$ 0
Andrew Ro
Chief Investment Officer & Director5.4yrsUS$18.88k0%
$ 0
Anthony Crisci
Chief Legal Officer & Chief Administrative Officer2.8yrsUS$424.83k0%
$ 0
Anthony Dolisi
Chief Commercial Officer3.4yrsNessun dato1.08%
$ 658.9
Jason Terrell
Chief Scientific Officer & Chief Medical Officer5.4yrsNessun dato0%
$ 0
Michelle Starr
Chief Marketing Officer3.6yrsNessun datoNessun dato
Richard Purcell
Executive Vice President of Research & Drug Development5.4yrsUS$68.33k0%
$ 0

5.4yrs

Durata media

56.5yo

Età media

Gestione esperta: GNBT's management team is seasoned and experienced (5.4 years average tenure).

Membri del Consiglio di amministrazione

NomePosizioneMandatoCompensazioneProprietà
Joseph Moscato
CEO, President & Chairman of the Board5.4yrsUS$623.08k0.36%
$ 219.0
Andrew Ro
Chief Investment Officer & Director5.4yrsUS$18.88k0%
$ 0
Brian McGee
Independent Director18.3yrsUS$47.20k0%
$ 0
Lawrence Salvo
Independent Director5.4yrsUS$18.88k0.26%
$ 160.2
Craig Eagle
Independent Director & Member of Scientific Advisory Board11.8yrsUS$47.20k0%
$ 0
James Anderson
Independent Director11yrsUS$118.33k0%
$ 0
Gary Noel
Member of Scientific Advisory Board1.7yrsNessun datoNessun dato
Mark Prioletti
Independent Director3.2yrsNessun dato0%
$ 0
John Sanders
Member of Scientific Advisory Board1.7yrsNessun datoNessun dato
Jonathan Davis
Member of Scientific Advisory Board1.7yrsNessun datoNessun dato

5.4yrs

Durata media

59yo

Età media

Consiglio di amministrazione esperto: GNBT's board of directors are considered experienced (5.4 years average tenure).